Teva Again Recalling Adrucil After More Rubber Pieces Found in Vials
Particulates have forced Teva to voluntarily recall lots of its anticancer therapy Adrucil for the second time since May, after silicone rubber pieces from a filler diaphragm and fluorouracil crystals were found in six lots of the product, totaling over 30,000 vials.
In early May, Teva recalled eight lots of the drug after finding the same types of particulates in vials. Teva spokeswoman Michele Pelkowski said that the two recalls are related, and the cause is still being investigated.
No reports of adverse events have been reported. A total of 6,001 packages are involved.
View the recall notice at www.fdanews.com/07-28-15-TevaRecall.pdf. — Kellen Owings